UPDATE: USPTO Board Rules for PacBio in Patent Interference Case with Life Technologies
February 01, 2011
UPDATE: USPTO Board Rules for PacBio in Patent Interference Case with Life Technologies
According to PacBio, the USPTO's Board of Patent Appeals and Interferences decision cancels all patent claims by Life Tech that were involved in the case.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Sequenom Gets USPTO Notification of Withdrawn Patent Issuance
December 17, 2012 / GenomeWeb Daily News - PacBio Q2 Revenues Down 31 Percent; Booked One Sequencer During Quarter
July 27, 2012 / GenomeWeb Daily News - Berlin Institute for Medical Systems Biology to Install PacBio RS
July 19, 2011 / In Sequence - Pacific Biosciences Targeting $15-$17 Share Price for IPO
October 5, 2010 / GenomeWeb Daily News - PacBio Named Senior Party in USPTO Interference Involving VisiGen Patent
March 31, 2009 / In Sequence